Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05131100
Korean Regulatory Post Marketing Surveillance for Somavert
Sponsor: Pfizer
View on ClinicalTrials.gov
Summary
Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)
Official title: KOREAN POST-MARKETING SURVEILLANCE FOR SOMAVERT
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
11
Start Date
2022-07-13
Completion Date
2025-11-10
Last Updated
2026-07-23
Healthy Volunteers
No
Conditions
Interventions
DRUG
Somavert
As provided in real world practice
Locations (1)
Pfizer
Seoul, South Korea